CFB
MEDP icon

Cullen/Frost Bankers’s Medpace MEDP Stock Holding History

Cullen/Frost Bankers’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-87
Closed -$41.8K – 1461
2026
Q1 		$41.8K Sell
87
-122
-58% -$62.5K ﹤0.01% 839
2025
Q4 		$117K Buy
209
+131
+168% +$74.4K ﹤0.01% 654
2025
Q3 		$40.1K Hold
78
– – ﹤0.01% 793
2025
Q2 		$24.5K Buy
78
+37
+90% +$11.1K ﹤0.01% 886
2025
Q1 		$12.5K Buy
41
+10
+32% +$3.36K ﹤0.01% 917
2024
Q4 		$10.3K Sell
31
-89
-74% -$30.2K ﹤0.01% 880
2024
Q3 		$40.1K Buy
120
+4
+3% +$1.52K ﹤0.01% 742
2024
Q2 		$47.8K Buy
116
+16
+16% +$6.34K ﹤0.01% 688
2024
Q1 		$40.4K Buy
+100
New +$35.2K ﹤0.01% 688
2023
Q4 		– Sell
-88
Closed -$21.3K – 1119
2023
Q3 		$21.3K Hold
88
– – ﹤0.01% 860
2023
Q2 		$21.1K Buy
+88
New +$18.3K ﹤0.01% 850

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Cullen/Frost Bankers's MEDP Position: Q2 2026 in Review

Cullen/Frost Bankers sold out of Medpace (MEDP) in Q2 2026, closing a stake of 87 shares — an estimated $41.8K sold.

Cullen/Frost Bankers first reported a position in MEDP in Q2 2023 and held it in 11 quarters. The position peaked at $117K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Cullen/Frost Bankers reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Cullen/Frost Bankers sold 87 Medpace shares in Q2 2026, an estimated $41.8K.
  • Cullen/Frost Bankers first reported a position in Medpace in Q2 2023 and held it in 11 quarters.
  • Cullen/Frost Bankers's Medpace position peaked at $117K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.